Woodline Partners’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-639,598
| Closed | -$30.4M | – | 1013 |
|
|
2025
Q3 | $30.4M | Sell |
639,598
-1,827,752
| -74% | -$88.5M | 0.14% | 195 |
|
|
2025
Q2 | $132M | Buy |
2,467,350
+1,986,614
| +413% | +$90.3M | 0.7% | 11 |
|
|
2025
Q1 | $19.5M | Buy |
480,736
+100,769
| +27% | +$4.27M | 0.13% | 230 |
|
|
2024
Q4 | $10.6M | Buy |
379,967
+87,499
| +30% | +$2.65M | 0.07% | 330 |
|
|
2024
Q3 | $8.39M | Buy |
292,468
+92,036
| +46% | +$2.4M | 0.07% | 328 |
|
|
2024
Q2 | $4.7M | Buy |
200,432
+71,991
| +56% | +$1.54M | 0.05% | 345 |
|
|
2024
Q1 | $3.24M | Buy |
+128,441
| New | +$3.08M | 0.03% | 399 |
|
